For more than 50 years, warfarin has been the standard of care for long-term anticoagulation therapy in the United States, but now the FDA has approved the first oral anticoagulant that could replace it.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Rights and permissions
About this article
Cite this article
Hughes, B. First oral warfarin alternative approved in the US. Nat Rev Drug Discov 9, 903–905 (2010). https://doi.org/10.1038/nrd3322
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd3322
This article is cited by
-
2010 in reflection
Nature Reviews Drug Discovery (2011)
-
Design of small-molecule thrombin inhibitors based on the cis-5-phenylproline scaffold
Russian Chemical Bulletin (2011)
